Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

PMID: 21788950
Journal: LEUKEMIA
Year: 2012
Reference: Leukemia. 2012 Jan;26(1):180-3. doi: 10.1038/leu.2011.189. Epub 2011 Jul 26.
Impact factor: 9.561
Publication type: Letter whit IF
Authors: , , , , , , , , , et al.
DOI: 10.1038/leu.2011.189

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

PMID: 21788950
Journal: LEUKEMIA
Year: 2012
Reference: Leukemia. 2012 Jan;26(1):180-3. doi: 10.1038/leu.2011.189. Epub 2011 Jul 26.
Impact factor:
Publication type: Letter whit IF
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1038/leu.2011.189

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.

PMID: 22485250
Journal: INTERNATIONAL JOURNAL OF ONCOLOGY
Year: 2012
Reference: Int J Oncol. 2012 Jul;41(1):317-24. doi: 10.3892/ijo.2012.1425. Epub 2012 Apr 3.
Impact factor: 2.399
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.3892/ijo.2012.1425

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.

PMID: 22485250
Journal: INTERNATIONAL JOURNAL OF ONCOLOGY
Year: 2012
Reference: Int J Oncol. 2012 Jul;41(1):317-24. doi: 10.3892/ijo.2012.1425. Epub 2012 Apr 3.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; et al.
DOI: 10.3892/ijo.2012.1425

[Erdheim-Chester disease: study of 12 cases.]

PMID: 22795496
Journal: MEDICINA CLINICA
Year: 2012
Reference: Med Clin (Barc). 2012 Oct 13;139(9):398-403. doi: 10.1016/j.medcli.2012.05.001. Epub 2012 Jul 12.
Impact factor: 1.385
Publication type: Editorial in national publication
Authors: , , , , , , , , , et al.
DOI: 10.1016/j.medcli.2012.05.001

[Erdheim-Chester disease: study of 12 cases.]

PMID: 22795496
Journal: MEDICINA CLINICA
Year: 2012
Reference: Med Clin (Barc). 2012 Oct 13;139(9):398-403. doi: 10.1016/j.medcli.2012.05.001. Epub 2012 Jul 12.
Impact factor:
Publication type: Editorial in national publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.medcli.2012.05.001

Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.

PMID: 21550727
Journal: CANCER TREATMENT REVIEWS
Year: 2012
Reference: Cancer Treat Rev. 2012 Apr;38(2):143-51. doi: 10.1016/j.ctrv.2011.03.006. Epub 2011 May 8.
Impact factor: 6.054
Publication type: Review in international publication
Authors: , , et al.
DOI: 10.1016/j.ctrv.2011.03.006

Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.

PMID: 21550727
Journal: CANCER TREATMENT REVIEWS
Year: 2012
Reference: Cancer Treat Rev. 2012 Apr;38(2):143-51. doi: 10.1016/j.ctrv.2011.03.006. Epub 2011 May 8.
Impact factor:
Publication type: Review in international publication
Authors: ; ; et al.
DOI: 10.1016/j.ctrv.2011.03.006

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

PMID: 22285168
Journal: LANCET ONCOLOGY
Year: 2012
Reference: Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26.
Impact factor: 22.589
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1016/S1470-2045(11)70393-X

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

PMID: 22285168
Journal: LANCET ONCOLOGY
Year: 2012
Reference: Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1016/S1470-2045(11)70393-X

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

PMID: 22167324
Journal: ENDOCRINE
Year: 2012
Reference: Endocrine. 2012 Apr;41(2):220-6. Epub 2011 Dec 14.
Impact factor: 1.416
Publication type: Review in international publication
Authors: , et al.
DOI: 10.1007/s12020-011-9579-6

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

PMID: 22167324
Journal: ENDOCRINE
Year: 2012
Reference: Endocrine. 2012 Apr;41(2):220-6. Epub 2011 Dec 14.
Impact factor:
Publication type: Review in international publication
Authors: ; et al.
DOI: 10.1007/s12020-011-9579-6

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

PMID: 21406443
Journal: EUROPEAN HEART JOURNAL
Year: 2012
Reference: Eur Heart J. 2012 Apr;33(7):822-8. Epub 2011 Mar 15.
Impact factor: 10.478
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1093/eurheartj/ehr061

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

PMID: 21406443
Journal: EUROPEAN HEART JOURNAL
Year: 2012
Reference: Eur Heart J. 2012 Apr;33(7):822-8. Epub 2011 Mar 15.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1093/eurheartj/ehr061

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

PMID: 23012255
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 Oct;23(10):2479-516.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: Schmoll, H J, Van Cutsem, E, Stein, A, Valentini, V, Glimelius, B, Haustermans, K, Nordlinger, B, van de Velde, C J, Balmana, J, Regula, J et al.
DOI: 10.1093/annonc/mds236

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

PMID: 23012255
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 Oct;23(10):2479-516.
Impact factor:
Publication type: Paper in international publication
Authors: Aderka, D; Arnold, D; Balmana, J; Barroso, S; Beets-Tan, R G; Bodoky, G; Cervantes, A; Ciardiello, F; Douillard, J Y; El Ghazaly, H et al.
DOI: 10.1093/annonc/mds236

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

PMID: 20674091
Journal: NEUROBIOLOGY OF AGING
Year: 2012
Reference: Neurobiol Aging. 2012 Jan;33(1):198.e15-24. Epub 2010 Jul 31.
Impact factor: 6.189
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1016/j.neurobiolaging.2010.06.016

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

PMID: 20674091
Journal: NEUROBIOLOGY OF AGING
Year: 2012
Reference: Neurobiol Aging. 2012 Jan;33(1):198.e15-24. Epub 2010 Jul 31.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1016/j.neurobiolaging.2010.06.016

[Ethics, equity and social determinants of health].

PMID: 22115543
Journal: Gaceta Sanitaria
Year: 2012
Reference: Gac Sanit. 2012 Mar-Apr;26(2):178-81. doi: 10.1016/j.gaceta.2011.08.007. Epub 2011 Nov 23.
Impact factor: 1.326
Publication type: Paper in national publication
Authors: Puyol, Angel et al.
DOI: 10.1016/j.gaceta.2011.08.007

[Ethics, equity and social determinants of health].

PMID: 22115543
Journal: Gaceta Sanitaria
Year: 2012
Reference: Gac Sanit. 2012 Mar-Apr;26(2):178-81. doi: 10.1016/j.gaceta.2011.08.007. Epub 2011 Nov 23.
Impact factor:
Publication type: Paper in national publication
Authors: Puyol, Angel et al.
DOI: 10.1016/j.gaceta.2011.08.007

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

PMID: 22266854
Journal: ONCOGENE
Year: 2012
Reference: Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.
Impact factor: 6.373
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1038/onc.2011.632

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

PMID: 22266854
Journal: ONCOGENE
Year: 2012
Reference: Oncogene. 2012 Nov 8;31(45):4778-88. doi: 10.1038/onc.2011.632. Epub 2012 Jan 23.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1038/onc.2011.632

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

PMID: 21520040
Journal: INTERNATIONAL JOURNAL OF CANCER
Year: 2012
Reference: Int J Cancer. 2012 Apr 1;130(7):1532-43. doi: 10.1002/ijc.26148. Epub 2011 Aug 12.
Impact factor: 5.444
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1002/ijc.26148

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

PMID: 21520040
Journal: INTERNATIONAL JOURNAL OF CANCER
Year: 2012
Reference: Int J Cancer. 2012 Apr 1;130(7):1532-43. doi: 10.1002/ijc.26148. Epub 2011 Aug 12.
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; ; ; ; ; ; et al.
DOI: 10.1002/ijc.26148

Publications

Publications searcher

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma.

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.

ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines.

[Erdheim-Chester disease: study of 12 cases.]

[Erdheim-Chester disease: study of 12 cases.]

Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.

Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

Estrogen receptor alpha gene variants are associated with Alzheimer's disease.

[Ethics, equity and social determinants of health].

[Ethics, equity and social determinants of health].

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.

Patronage:

Collaborating:

Accreditations: